Just issued.
Australian healthcare company Prima BioMed Ltd (ASX: PRR) (Prima) is pleased to announce that it has commenced patient enrollment into CANVAS (CANcer VAccine Study), its major late-stage clinical trial for the CVacTM ovarian cancer therapy vaccine.
Highlights
• Prima BioMed has confirmed that the first patient has been enrolled in CANVAS (CANcer VAccine Study), its pivotal clinical trial for the CVacTM ovarian cancer therapy vaccine.
• This represents a key major milestone in the development timeline for the CVacTM vaccine; the first patient was recruited in the United States.
• CANVAS is an 800 patient trial which will be conducted across 150 centres in 22 countries in Europe, Australasia and the US.
• CANVAS aims to establish that CVacTM is able to;
o definitively extend the time in remission after surgery and chemotherapy
o extend overall life expectancy
o improve quality of life for patients
o assess pharmacoeconomic parameters
• Prima expects to ramp-up enrollment through sites in Europe, Australasia and the US through 2012; patient enrollment into the study is expected to be complete within 2 years or less.
Prima BioMed chief executive officer Martin Rogers said: “We are excited to have commenced patient enrollment for our major CVacTM trial. This represents a significant milestone in CVacTM’s development timeline to date. The ability to embark on such a large scale study across multiple sites in different continents is a testament to the commitment and expertise of the Prima team, and also for the potential for CVacTM to provide a viable, commercially available treatment option for ovarian cancer patients globally.”
- Forums
- ASX - By Stock
- company press release on 1 trial patient
Just issued.Australian healthcare company Prima BioMed Ltd (ASX:...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
31.0¢ |
Change
-0.005(1.59%) |
Mkt cap ! $450.9M |
Open | High | Low | Value | Volume |
31.5¢ | 31.8¢ | 31.0¢ | $897.5K | 2.872M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 79201 | 31.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.5¢ | 138883 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 79201 | 0.310 |
18 | 240613 | 0.305 |
26 | 668636 | 0.300 |
7 | 138083 | 0.295 |
11 | 229590 | 0.290 |
Price($) | Vol. | No. |
---|---|---|
0.315 | 138883 | 3 |
0.320 | 47330 | 2 |
0.325 | 36000 | 2 |
0.330 | 199775 | 4 |
0.335 | 196676 | 5 |
Last trade - 16.10pm 08/10/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |